Health And Wellness Coaching To Improve Patient Activation And Adherence To Healthy Habits In Differentiated Thyroid Cancer Care

Overview

About this study

The purpose of this study is to establish feasibility and acceptability of integrating HWC into thyroid cancer survivorship care.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults ≥18 years

  • Histologically confirmed papillary or follicular thyroid carcinoma

  • Status post total thyroidectomy ± radioactive iodine therapy

  • Receiving levothyroxine monotherapy (no T3 or desiccated thyroid products)

  • TSH <4 µIU/mL at ≥3 months post-thyroidectomy

  • English proficiency

  • Ability to provide informed consent

Exclusion Criteria:

  • Medullary or anaplastic thyroid carcinoma

  • Current systemic therapy for thyroid or other cancers

  • Cognitive or psychiatric impairment precluding participation

  • Inability to complete study procedures

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 01/20/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Abd Moain Abu Dabrh

Contact us for the latest status

Contact information:

Clinical Studies Unit

(904) 953-2255

More information

Publications

Publications are currently not available